infomed-screen
ACE-Hemmer oder Angiotensin-Rezeptorantagonisten bei Diabetes?
- m -- Cheng J, Zhang W, Han F et al. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis. JAMA [Link]
- Zusammenfassung: Markus Gnädinger